Gene therapy in autoimmune disease.

Area of Science:

• Immunology
• Gene Therapy
• Autoimmune Diseases

Background:

• Autoimmune diseases involve the immune system attacking the body's own tissues.
• Gene therapy offers a potential strategy to modulate immune responses in autoimmunity.
• Dendritic cells and T cells are explored as vectors for targeted gene delivery.

Purpose of the Study:

• To investigate the pathogenesis of autoimmunity through gene therapy research.
• To evaluate the efficacy and safety of using transduced dendritic cells and antigen-specific T cells for gene therapy.
• To assess the feasibility and safety of gene transfer in a human clinical trial for rheumatoid arthritis.

Main Methods:

• Utilizing transduced dendritic cells and antigen-specific T cells as gene delivery vehicles.
• Employing bioluminescence imaging to track cell trafficking and homing in vivo.
• Conducting a phase I clinical trial to evaluate gene transfer in rheumatoid arthritis patients.

Main Results:

• Gene therapy applications using specific cell types have demonstrated reliability and effectiveness.
• Bioluminescence imaging successfully visualized in vivo cell trafficking and homing.
• A phase I clinical trial in rheumatoid arthritis patients was completed, providing initial safety and feasibility data.

Conclusions:

• Gene therapy, particularly with engineered immune cells, offers a promising avenue for treating autoimmune diseases.
• In vivo imaging techniques are valuable for understanding cell-based therapy dynamics.
• The completed phase I trial represents a crucial first step towards human application of gene therapy for rheumatoid arthritis.